<DOC>
	<DOCNO>NCT02224014</DOCNO>
	<brief_summary>Study investigate safety efficacy patient insomnia , receive Lendormin D tablet condition normal clinical practice .</brief_summary>
	<brief_title>Lendormin DÂ® Tablet ( Drug Use Result Survey )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Brotizolam</mesh_term>
	<criteria>Patients insomnia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>